Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early‐onset Alzheimer's disease
Open Access
- 26 July 2023
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S9) , S49-S63
Abstract
INTRODUCTION: We used sex and apolipoprotein E ε4 (APOE ε4) carrier status as predictors of pathologic burden in early‐onset Alzheimer's disease (EOAD).METHODS: We included baseline data from 77 cognitively normal (CN), 230 EOAD, and 70 EO non‐Alzheimer's disease (EOnonAD) participants from the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS). We stratified each diagnostic group by males and females, then further subdivided each sex by APOE ε4 carrier status and compared imaging biomarkers in each stratification. Voxel‐wise multiple linear regressions yielded statistical brain maps of gray matter density, amyloid, and tau PET burden.RESULTS: EOAD females had greater amyloid and tau PET burdens than males. EOAD female APOE ε4 non‐carriers had greater amyloid PET burdens and greater gray matter atrophy than female ε4 carriers. EOnonAD female ε4 non‐carriers also had greater gray matter atrophy than female ε4 carriers.DISCUSSION: The effects of sex and APOE ε4 must be considered when studying these populations.HIGHLIGHTS: Novel analysis examining the effects of biological sex and apolipoprotein E ε4 (APOE ε4) carrier status on neuroimaging biomarkers among early‐onset Alzheimer's disease (EOAD), early‐onset non‐AD (EOnonAD), and cognitively normal (CN) participants. Female sex is associated with greater pathology burden in the EOAD cohort compared to male sex. The effect of APOE ε4 carrier status on pathology burden was the most impactful in females across all cohorts.Keywords
This publication has 41 references indexed in Scilit:
- Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differencesClinical Epidemiology, 2014
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 2011
- Pittsburgh Compound B-Negative Dementia—A Possibility of Misdiagnosis of Patients With Non-Alzheimer Disease-Type Dementia as Having ADJournal of Geriatric Psychiatry and Neurology, 2011
- Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's diseaseNeurobiology of Aging, 2011
- Oophorectomy, menopause, estrogen treatment, and cognitive aging: Clinical evidence for a window of opportunityBrain Research, 2011
- Effects of demographic factors on cortical thickness in Alzheimer's diseaseNeurobiology of Aging, 2011
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Number of children is associated with neuropathology of Alzheimer's disease in womenNeurobiology of Aging, 2009
- Most rapid cognitive decline in APOE ε4 negative Alzheimer's disease with early onsetPsychological Medicine, 2009
- Apolipoprotein E ε4 Allele Frequency and Age at Onset of Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2006